We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+10.25%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$339B
AUM Growth
+$32.7B
Cap. Flow
+$7.03B
Cap. Flow %
2.08%
Top 10 Hldgs %
18.14%
Holding
3,647
New
148
Increased
2,572
Reduced
501
Closed
58

Sector Composition

Rank Sector Weight
1 Technology 21.96%
2 Financials 12.71%
3 Healthcare 11.98%
4 Consumer Discretionary 10.85%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPCE icon
3376
Neuropace
NPCE
$439M
$176K ﹤0.01%
17,448
LSF icon
3377
Laird Superfood
LSF
$45.8M
$172K ﹤0.01%
13,138
-1,284
-9% -$19.9K
LXU icon
3378
LSB Industries
LXU
$783M
$172K ﹤0.01%
15,524
+1
+0% +$9
NEXI
3379
DELISTED
NexImmune, Inc. Common Stock
NEXI
$172K ﹤0.01%
1,485
-97
-6% -$23.3K
IRON icon
3380
Disc Medicine
IRON
$2.94B
$169K ﹤0.01%
1,925
TBIO
3381
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$169K ﹤0.01%
867
AFIB
3382
DELISTED
Acutus Medical Inc
AFIB
$168K ﹤0.01%
49,121
ISO
3383
DELISTED
IsoPlexis Corporation Common Stock
ISO
$168K ﹤0.01%
+18,176
New +$202K
BDSX icon
3384
Biodesix
BDSX
$220M
$167K ﹤0.01%
1,570
IBEX icon
3385
IBEX
IBEX
$473M
$165K ﹤0.01%
12,767
ABOS icon
3386
Acumen Pharmaceuticals
ABOS
$155M
$163K ﹤0.01%
24,037
PNT
3387
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$163K ﹤0.01%
29,078
EMWP
3388
DELISTED
Eros Media World PLC
EMWP
$162K ﹤0.01%
33,678
OKUR
3389
OnKure Therapeutics
OKUR
$154M
$161K ﹤0.01%
1,883
+546
+41% +$40.1K
SRTA
3390
Strata Critical Medical Inc
SRTA
$434M
$160K ﹤0.01%
18,079
FOA icon
3391
Finance of America Companies
FOA
$203M
$160K ﹤0.01%
4,013
-3,699
-48% -$175K
ELMS
3392
DELISTED
Electric Last Mile Solutions, Inc. Class A Common stock
ELMS
$157K ﹤0.01%
22,316
PRTH icon
3393
Priority Technology Holdings
PRTH
$535M
$156K ﹤0.01%
21,956
HPK icon
3394
HighPeak Energy
HPK
$903M
$155K ﹤0.01%
10,561
SD icon
3395
SandRidge Energy
SD
$514M
$155K ﹤0.01%
14,792
VWE
3396
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
$155K ﹤0.01%
13,061
RLYB icon
3397
Rallybio
RLYB
$84.5M
$154K ﹤0.01%
2,010
+204
+11% +$23.7K
WEAV icon
3398
Weave Communications
WEAV
$520M
$154K ﹤0.01%
+10,114
New +$170K
MBII
3399
DELISTED
Marrone Bio Innovations, Inc.
MBII
$153K ﹤0.01%
212,325
PLM
3400
DELISTED
PolyMet Mining Corp.
PLM
$153K ﹤0.01%
61,184

Similar funds

Charles Schwab's Q4 2021 Portfolio in Review

As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
  • Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
  • Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
  • Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
  • Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
  • Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
  • Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.

Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.